Myoblasts from affected and non‐affected FSHD muscles exhibit morphological differentiation defects
Open Access
- 1 January 2010
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (1-2) , 275-289
- https://doi.org/10.1111/j.1582-4934.2008.00368.x
Abstract
Facioscapulohumeral dystrophy (FSHD) is a muscular hereditary disease with a prevalence of 1 in 20,000 caused by a partial deletion of a subtelomeric repeat array on chromosome 4q. However, very little is known about the pathogenesis as well as the molecular and biochemical changes linked to the progressive muscle degeneration observed in these patients. Several studies have investigated possible pathophysiological pathways in FSHD myoblasts and mature muscle cells but some of these reports were apparently in contradiction. The discrepancy between these studies may be explained by differences between the sources of myoblasts. Therefore, we decided to thoroughly analyze affected and unaffected muscles from patients with FSHD in terms of vulnerability to oxidative stress, differentiation capacity and morphological abnormalities. We have established a panel of primary myoblast cell cultures from patients affected with FSHD and matched healthy individuals. Our results show that primary myoblasts are more susceptible to an induced oxidative stress than control myoblasts. Moreover, we demonstrate that both types of FSHD primary myoblasts differentiate into multi-nucleated myotubes, which present morphological abnormalities. Whereas control myoblasts fuse to form branched myotubes with aligned nuclei, FSHD myoblasts fuse to form either thin and branched myotubes with aligned nuclei or large myotubes with random nuclei distribution. In conclusion, we postulate that these abnormalities could be responsible for muscle weakness in patients with FSHD and provide an important marker for FSHD myoblasts.Keywords
This publication has 40 references indexed in Scilit:
- A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: Implications for the facio-scapulo-humeral dystrophyGenome Research, 2007
- DUX4 , a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1Proceedings of the National Academy of Sciences, 2007
- Specific Sequence Variations within the 4q35 Region Are Associated with Facioscapulohumeral Muscular DystrophyAmerican Journal of Human Genetics, 2007
- Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle BiopsiesThe International Journal of Cell Cloning, 2007
- Facioscapulohumeral muscular dystrophyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblastsProceedings of the National Academy of Sciences, 2006
- Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1Nature, 2005
- Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophyAnnals of Neurology, 2005
- Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patientsGene Therapy, 2005
- Monocarboxylate transporters, blood lactate removal after supramaximal exercise, and fatigue indexes in humansJournal of Applied Physiology, 2005